6.
Hurtado D, Molina-Porcel L, Iba M, Aboagye A, Paul S, Trojanowski J
. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Am J Pathol. 2010; 177(4):1977-88.
PMC: 2947292.
DOI: 10.2353/ajpath.2010.100346.
View
7.
Mezias C, LoCastro E, Xia C, Raj A
. Connectivity, not region-intrinsic properties, predicts regional vulnerability to progressive tau pathology in mouse models of disease. Acta Neuropathol Commun. 2017; 5(1):61.
PMC: 5556602.
DOI: 10.1186/s40478-017-0459-z.
View
8.
Anand C, Maia P, Torok J, Mezias C, Raj A
. The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) models. Sci Rep. 2022; 12(1):21170.
PMC: 9729195.
DOI: 10.1038/s41598-022-25131-3.
View
9.
Ahmed Z, Cooper J, Murray T, Garn K, McNaughton E, Clarke H
. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol. 2014; 127(5):667-83.
PMC: 4252866.
DOI: 10.1007/s00401-014-1254-6.
View
10.
Braak H, Del Tredici K
. Alzheimer's pathogenesis: is there neuron-to-neuron propagation?. Acta Neuropathol. 2011; 121(5):589-95.
DOI: 10.1007/s00401-011-0825-z.
View
11.
Zhou J, Gennatas E, Kramer J, Miller B, Seeley W
. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron. 2012; 73(6):1216-27.
PMC: 3361461.
DOI: 10.1016/j.neuron.2012.03.004.
View
12.
Kaufman S, Sanders D, Thomas T, Ruchinskas A, Vaquer-Alicea J, Sharma A
. Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo. Neuron. 2016; 92(4):796-812.
PMC: 5392364.
DOI: 10.1016/j.neuron.2016.09.055.
View
13.
Holmes B, Furman J, Mahan T, Yamasaki T, Mirbaha H, Eades W
. Proteopathic tau seeding predicts tauopathy in vivo. Proc Natl Acad Sci U S A. 2014; 111(41):E4376-85.
PMC: 4205609.
DOI: 10.1073/pnas.1411649111.
View
14.
Zempel H, Dennissen F, Kumar Y, Luedtke J, Biernat J, Mandelkow E
. Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture. J Biol Chem. 2017; 292(29):12192-12207.
PMC: 5519369.
DOI: 10.1074/jbc.M117.784702.
View
15.
Braak H, Braak E
. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82(4):239-59.
DOI: 10.1007/BF00308809.
View
16.
Palmqvist S, Janelidze S, Quiroz Y, Zetterberg H, Lopera F, Stomrud E
. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA. 2020; 324(8):772-781.
PMC: 7388060.
DOI: 10.1001/jama.2020.12134.
View
17.
Murray M, Graff-Radford N, Ross O, Petersen R, Duara R, Dickson D
. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 2011; 10(9):785-96.
PMC: 3175379.
DOI: 10.1016/S1474-4422(11)70156-9.
View
18.
Torok J, Maia P, Verma P, Mezias C, Raj A
. Emergence of directional bias in tau deposition from axonal transport dynamics. PLoS Comput Biol. 2021; 17(7):e1009258.
PMC: 8345857.
DOI: 10.1371/journal.pcbi.1009258.
View
19.
Boluda S, Iba M, Zhang B, Raible K, Lee V, Trojanowski J
. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains. Acta Neuropathol. 2014; 129(2):221-37.
PMC: 4305460.
DOI: 10.1007/s00401-014-1373-0.
View
20.
Chiba S, Takada E, Tadokoro M, Taniguchi T, Kadoyama K, Takenokuchi M
. Loss of dopaminoreceptive neuron causes L-dopa resistant parkinsonism in tauopathy. Neurobiol Aging. 2011; 33(10):2491-505.
DOI: 10.1016/j.neurobiolaging.2011.11.002.
View